Answer
Yes, the Alliance Pharmaceuticals prochlorperazine maleate 3 mg buccal tablets product is indicated for symptomatic treatment of vertigo due to Ménière’s disease, labyrinthitis and other causes.
Sources for this answer
- Prochlorperazine 3 mg Buccal TabletsAlliance Pharmaceuticals · emc · SmPC §4.1 Therapeutic Indications · Version 5Document updated
Sources checked